Leerink Swann Starts Alnylam Pharmaceuticals (ALNY) at Outperform; Positive Phase 1 Results From ALN-TTR-02
Tweet Send to a Friend
Leerink Swann initiates coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY) with a Outperform. PT $24.00.
Analyst, Irene Lau, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Irene Lau, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
